Initial PET evaluation of [F-18] fluoro-HEAT for central alpha-1 noradrenergic receptor imaging
E Petrie, J Grierson, D Cross, A Obata, B Lewellen… - 2010 - Soc Nuclear Med
107 Objectives Alpha-1 noradrenergic receptors are thought to contribute to the
pathophysiology of anxiety symptoms in patients with post-traumatic stress disorder (PTSD) …
pathophysiology of anxiety symptoms in patients with post-traumatic stress disorder (PTSD) …
[11C] R129144 as a putative PET ligand for the adrenergic α2 receptor
A Windhorst, M Mooijer, X Langlois, L Kennis… - 2010 - Soc Nuclear Med
32 Objectives A PET ligand for the adrenergic α2 receptor (α2AR) would be of interest for
accelerating drug development aimed at this receptor. R129144 has high affinity and …
accelerating drug development aimed at this receptor. R129144 has high affinity and …
Development of F-18 Labeled Radiotracers for PET Imaging of Brain Alpha-1 Noradrenergic Receptors: Potential PTSD Vulnerability and Diagnostic Biomarkers
EC Petrie, DJ Cross, J Grierson, SEATTLE UNIV WA - 2012 - apps.dtic.mil
Increased central nervous system CNS alpha-1 noradrenergic receptor 1NAR responsivity
may be a vulnerability andor diagnostic biomarker for posttraumatic stress disorder PTSD …
may be a vulnerability andor diagnostic biomarker for posttraumatic stress disorder PTSD …
Synthesis and biological evaluation of fluorine-18 labeled RS-15385-197 analogs: Potent and selective alpha-2 adrenergic receptor radioligands for PET
JD Enas, HF VanBrocklin, TF Budinger, RD Clark - 1997 - osti.gov
Aberrations in the {alpha}{sub 2}-adrenergic receptor system have been implicated in a
number of disease states including hypertension, drug abuse, depression, and …
number of disease states including hypertension, drug abuse, depression, and …
18F-XTRA PET for enhanced imaging of the extrathalamic α4β2 nicotinic acetylcholine receptor
Reduced density of the α4β2 nicotinic acetylcholine receptor (α4β2-nAChR) in the cortex
and hippocampus of the human brain has been reported in aging and patients with …
and hippocampus of the human brain has been reported in aging and patients with …
[HTML][HTML] Synthesis and biological evaluation of [11C] MK-912 as an α2-adrenergic receptor radioligand for PET studies
C Shiue, RC Pleus, GG Shiue, JA Rysavy… - Nuclear medicine and …, 1998 - Elsevier
In vitro studies showed that MK-912 ((2S, 12bS) 1', 3'-dimethylspiro (1, 3, 4, 5', 6, 6', 7, 12b-
octahydro-2H-benzo [b] furo [2, 3-a] quinolizine)-2, 4'-pyrimidin-2'-one) is a potent α2 …
octahydro-2H-benzo [b] furo [2, 3-a] quinolizine)-2, 4'-pyrimidin-2'-one) is a potent α2 …
Synthesis and biological evaluation of [{sup 11} C] MK-912 as an {alpha}{sub 2}-adrenergic receptor radioligand for PET studies
S Chyngyann, RC Pleus, GG Shiue, JA Rysavy… - Nuclear Medicine and …, 1998 - osti.gov
In vitro studies showed that MK-912 ((2S, 12bS) 1', 3'-dimethylspiro (1, 3, 4, 5', 6, 6', 7, 12b-
octahydro-2H-benzo [b] furo [2, 3-a] quinolizine)-2, 4'-pyrimidin-2'-one) is a potent …
octahydro-2H-benzo [b] furo [2, 3-a] quinolizine)-2, 4'-pyrimidin-2'-one) is a potent …
Development of a carbon-11 PET radiotracer based on 1, 4-benzodioxane derivatives for brain alpha2C adrenergic receptors
2860 Introduction: The a2C-adrenergic receptors (a2C-ARs) are presynaptic receptors that
inhibit neurotransmitter release from adrenergic brain terminals and are targets of interest for …
inhibit neurotransmitter release from adrenergic brain terminals and are targets of interest for …
18F-Nifene: Efficacy as PET imaging agent of Nicotinic α4β2 Receptors from Mice to Humans
490 Objectives We have developed the agonist 18 F-nifene for PET imaging studies of
nicotinic α4β2 receptors in various CNS disorders. Upon successful completion of rodent …
nicotinic α4β2 receptors in various CNS disorders. Upon successful completion of rodent …
Efficient synthesis of [18F]-β-blockers:[18F]-S-fluoro-toliprolol and exaprolol
K Stephenson, E van Oosten, A Wilson, J Meyer… - 2008 - Soc Nuclear Med
1225 Objectives: β-Adrenergic receptors (βARs) have been evaluated with PET for both
heart and neurological imaging. Current methods to prepare [18 F]-labeled β-blockers …
heart and neurological imaging. Current methods to prepare [18 F]-labeled β-blockers …